1. Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
2. Chal JJ, Pourquié O. Making muscle: skeletal myogenesis in vivo
and in vitro. Development. 2017;144(12):2104-2122. 10.1242/
dev.151035
3. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected
cDNA converts fibroblasts to myoblasts. Cell. 1987;51:987-1000.
4. Constantinides PG, Jones PA, Gevers W. Functional striated muscle
cells from non-myoblast precursors following 5-azacytidine treatment. Nature. 1977;267:364-366.
5. Tanaka A, Woltjen K, Miyake K, et al. Efficient and reproducible
myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS One. 2013;8:e61540.
6. Yasuno T, Osafune K, Sakurai H, et al. Functional analysis of iPSC-
derived myocytes from a patient with carnitine palmitoyltransferase II deficiency. Biochem Biophys Res Commun. 2014;448:175-181.
7. Shoji E, Sakurai H, Nishino T, et al. Early pathogenesis of Duchenne
muscular dystrophy modelled in patient-derived human induced
pluripotent stem cells. Sci Rep. 2015;5:12831.
8. Gu C, Yang Y, Sompallae R, et al. A single CRISPR-C as9 deletion
strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-
derived muscle cells. Cell Stem Cell.
2016;18:533-540.
9. Bitzer M, Armeanu S, Lauer UM, Neubert WJ. Sendai virus vectors
as an emerging negative-strand RNA viral vector system. J Gene
Med. 2003;5:543-553.
10. Nishimura K, Sano M, Ohtaka M, et al. Development of defective and persistent Sendai virus vector: a unique gene delivery/
expression system ideal for cell reprogramming. J Biol Chem.
2011;286:4760-4771.
11. Ban H, Nishishita N, Fusaki N, et al. Efficient generation of
transgene-free human induced pluripotent stem cells (iPSCs) by
temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U. S.
A. 2011;108:14234-14239.
12. Goto K, Imamura K, Komatsu K, et al. Simple derivation of spinal
motor neurons from ESCs/iPSCs using sendai virus vectors. Mol
Ther Methods Clin Dev. 2017;4:115-125.
13. Li H-O, Zhu Y-F, Asakawa M, et al. A Cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol. 2000;74(14):6564-6569.
14. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient
induction of transgene-free human pluripotent stem cells using
a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Japan Acad Ser B Phys Biol Sci.
2009;85(8):348-362. 10.2183/pjab.85.348
15. Kondo T, Imamura K, Funayama M, et al. iPSC-based compound
screening and in vitro trials identify a synergistic anti-amyloid β
combination for Alzheimer’s disease. Cell Rep. 2017;21:2304-2312.
16. Maffioletti SM, Gerli MFM, Ragazzi M, et al. Efficient derivation
and inducible differentiation of expandable skeletal myogenic
cells from human ES and patient-
specific iPS cells. Nat Protoc.
2015;10:941-958.
17. Akiyama T, Sato S, Chikazawa-Nohtomi N, et al. Efficient differentiation of human pluripotent stem cells into skeletal muscle cells by
18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. TAN et al.
combining RNA-based MYOD1-expression and POU5F1-silencing.
Sci Rep. 2018;8:1189.
Weldon JE, Pastan I. A guide to taming a toxin–Recombinant
immunotoxins constructed from Pseudomonas exotoxin A for
the treatment of cancer. FEBS J. 2011;278(23):4683-4700.
10.1111/j.1742-4658.2011.08182.x
Tateno H, Onuma Y, Ito Y, et al. Elimination of tumorigenic human
pluripotent stem cells by a recombinant lectin-toxin fusion protein.
Stem Cell Rep. 2015;4(5):811-820. 10.1016/j.stemcr.2015.02.016.
Tateno H, Saito S, Saito S. Engineering of a potent recombinant
lectin-toxin fusion protein to eliminate human pluripotent stem
cells. Molecules. 2017;22(7):1151.
Juhas M, Engelmayr GC, Fontanella AN, Palmer GM, Bursac N.
Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci U S A.
2014;111(15):5508-5513. 10.1073/pnas.1402723111
Madden L, Juhas M, Kraus WE, Truskey GA, Bursac N. Bioengineered
human myobundles mimic clinical responses of skeletal muscle to
drugs. Elife. 2015;4:e04885.
Kokubu Y, Nagino T, Sasa K, et al. Phenotypic drug screening for
dysferlinopathy using patient-
derived induced pluripotent stem
cells. Stem Cells Transl Med. 2019;8:1017-1029.
Fujie Y, Fusaki N, Katayama T, et al. New type of Sendai virus vector
provides transgene-free iPS cells derived from chimpanzee blood.
PLoS One. 2014;9:e113052.
Sugiyama Y, Suzuki A, Kishikawa M, et al. Muscle develops a specific form of small heat shock protein complex composed of MKBP/
HSPB2 and HSPB3 during myogenic differentiation. J Biol Chem.
2000;275:1095-1104.
Clerico EM, Tilitsky JM, Meng W, Gierasch LM. How Hsp70 molecular machines interact with their substrates to mediate diverse physiological functions HHS public access. J Mol Biol.
2015;427:1575-1588.
Forcales SV, Puri PL. Signaling to the chromatin during skeletal
myogenesis: novel targets for pharmacological modulation of gene
expression. Semin Cell Dev Biol. 2005;16:596-611.
McArdle A, Broome CS, Kayani AC, et al. HSF expression in skeletal
muscle during myogenesis: implications for failed regeneration in
old mice. Exp Gerontol. 2006;41:497-500.
Barone R, Macaluso F, Sangiorgi C, et al. Skeletal muscle Heat shock
protein 60 increases after endurance training and induces peroxisome proliferator-activated receptor gamma coactivator 1 α1 expression. Nat. Publ. Gr. 2015;6(1):19781. 10.1038/srep19781
S U P P O R T I N G I N FO R M AT I O N
Additional supporting information may be found online in the
Supporting Information section.
How to cite this article: Tan GW, Kondo T, Imamura K, et al.
Simple derivation of skeletal muscle from human pluripotent
stem cells using temperature-sensitive Sendai virus vector. J
Cell Mol Med. 2021;25:9586–9596. https://doi.org/10.1111/
jcmm.16899
...
論文の公開元へ
